| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0e2dabae7f011ed6f9dfc850db5bda2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4953
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4973
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 |
| filingDate |
2000-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c26591024c8f05c627bab662405be4c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40e21121b394fd24928685a9d15049e6 |
| publicationDate |
2002-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1020192-B1 |
| titleOfInvention |
Composition against cellulitis |
| abstract |
Composition comprises: (a) theophylline and/or a theophylline derivative; (b) furosemide and/or a furosemide derivative; (c) a combination of troxerutin and carbazochome and/or a combination of troxerutin and carbazochome derivatives and/or a horse-chestnut extract; and (d) lidocaine and/or procaine and/or their derivatives. Composition comprises: (a) theophylline and/or a theophylline derivative; (b) furosemide (4-chloro-2-furfurylamino-5-sulfamoylbenzoic acid) and/or a furosemide derivative; (c) a combination of troxerutin (3',4',7-tris-O-(2-hydroxyethyl)-rutin) and carbazochome (3-hydroxy-1-methyl-5,6-indolinedione 5- semicarbazone) and/or a combination of troxerutin and carbazochome derivatives and/or a horse-chestnut extract; and (d) lidocaine and/or procaine and/or their derivatives. Independent claims are also included for the following: (1) use of the above composition as a cosmetic or medicament; (2) cosmetic treatment of cellulite comprising applying the above composition intracutaneously or by microinjection to the affected skin area. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859617-B2 |
| priorityDate |
1999-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |